China International Capital Corp
-
Shanghai Dazhong Public Utilities Co and VPower Group International Holdings seem unfazed by any market mayhem that may follow the US presidential election, as both prepare to launch $300m Hong Kong IPOs on Thursday this week. -
Primary activity in the Asia ex-Japan bond market was quiet on Monday as issuers and investors alike put activities on pause while they wait for the US presidential election results to be announced on Wednesday local time.
-
CICC is acquiring mainland rival China Investment Securities Co in an all-share deal worth Rmb16.7bn ($2.5bn), as the lender looks to scale up in wealth management and retail brokerage.
-
Guangdong Kanghua Healthcare Co priced its Hong Kong IPO at the bottom of expectations on Tuesday, as bankers blamed the poor aftermarket of recent listings for weighing on investor sentiment.
-
Mason Financial Holdings has proposed a rights issue of over 20bn new shares in an attempt to raise HK$2.9bn ($373.9m) of fresh capital.
-
Chinese fashion house JNBY sealed a HK$800.0m ($103.1m) IPO this week after pricing off the bottom of guidance, according to a source close to the deal.
-
Guangdong Kanghua Healthcare Co has gone live with its Hong Kong IPO and begun taking orders for a HK$1.2bn ($154.7m) listing.
-
Bank of Communications Financial Leasing Co snagged $1.5bn from a dual-tranche offering on Tuesday, as it opted for a slightly different structure to its past transactions.
-
Bank of Communications Financial Leasing Co launched its second dual tranche dollar bond of 2016 Tuesday, following a global roadshow last week.
-
China Resources Pharmaceutical Group priced its Hong Kong IPO near the middle of expectations on Friday morning, raising HK$14bn ($1.8bn) after investors stormed into the trade.
-
China Resources Pharmaceutical Group, Samsung BioLogics and ZTO Express all have investors clamouring to join their IPOs, as they look to raise a combined $5.2bn.
-
China Resources Pharmaceutical Group has tightened the price range on its IPO, putting it on track to raise up to HK$14.8bn ($1.9bn), according to a banker on the deal.
